{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22"}],"title":"Complete Response"},{"measurements":[{"groupId":"OG000","value":"5"}],"title":"Partial Response"},{"measurements":[{"groupId":"OG000","value":"4"}],"title":"Early Death/NE"},{"measurements":[{"groupId":"OG000","value":"2"}],"title":"No Response/Stable Disease"},{"measurements":[{"groupId":"OG000","value":"8"}],"title":"Progressed"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"41"}],"units":"Participants"}],"description":"Best disease response measured within 100 days from hematopoietic stem cell (HSC) infusion on day 0 using disease specific response criteria defined in the protocol","groups":[{"description":"All patients enrolled on study","id":"OG000","title":"All Patients"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"from start of conditioning on day -6 or -5 through day +100 after HSC infusion","title":"Day 100 Best Response","type":"PRIMARY","unitOfMeasure":"Participants"}